Global and United States Clinical Trial Imaging Market Report & Forecast 2022-2028

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Market Analysis and Insights: Global and United States Clinical Trial Imaging Market
This report focuses on global and United States Clinical Trial Imaging market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Clinical Trial Imaging market size is estimated to be worth US$ 1527.1 million in 2022 and is forecast to a readjusted size of US$ 2330.6 million by 2028 with a CAGR of 7.3% during the review period. Fully considering the economic change by this health crisis, by Type, In-house Imaging Service accounting for % of the Clinical Trial Imaging global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharmaceutical Companies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
According to the Segmentation of types, all the market of Clinical Trial Imaging can be divided into In-house Imaging Service and Central Imaging Service. The Central Imaging Service, it holds a comparatively larger share in global market, which accounts for about 69% in 2019.
Based on the Clinical Trial Imaging application, the Clinical Trial Imaging market is sub-segmented into several major Application, like Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others, etc. Pharmaceutical Companies and Biotechnology Companies are the most important applications, which holds nearly 1/3 and 1/4 of the market in 2019.
From the view of region, North America and Europe have a larger market share in 2019 which account for about 1/3 and 27%, and will witness a stable growth in following years. Asia-Pacific and India hold a big market share also, and they will witness the comparatively bigger market share in the future.
The world TOP 5 players in the Clinical Trial Imaging market are ICON, ERT, McLaren, Bioclinica, Parexel. These Top 5 companies currently account for more than 43% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Global Clinical Trial Imaging Scope and Market Size
Clinical Trial Imaging market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Clinical Trial Imaging market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO